Under way, not recruiting
Benefit of Cone-beam CT and Robotic-Assisted Bronchoscopy During Bronchoscopy
NCT06489678 · University of Zurich · Updated 5 May 2026
- What is being tested
- Robotic Assisted Bronchoscopy
- For
- Lung Neoplasms; Diagnosis; Lung Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 300 people. The full rules are on the registry page.
- Where
- Switzerland
- When
- Starts or started 25 June 2024, ends 30 July 2027. Registered 8 July 2024.
- Results
- None posted yet.
In the researchers' words
This randomized controlled trial evaluates the integration of cone-beam computed tomography (CBCT) and robotic-assisted bronchoscopy (RAB) for diagnosing pulmonary lesions, hypothesizing improved diagnostic yield compared to traditional methods. The trial involves 2 study arms (2x46 lesions) over 24 months with 12 months of follow-up and the diagnostic yield (ATS 2024 criteria) as the primary endpoint.
Sites
- University Hospital ZurichZurich, Canton of Zurich, Switzerland